Elanco Animal Health has entered into an agreement with Connecticut-based TriRx Pharmaceuticals, a global contract development and manufacturing organization (CDMO), for the sale of the company’s sites in Shawnee, KS, and Speke, UK.   The sale of the sites includes the physical assets at both locations along with the transfer of about 600 employees. The companies have also entered into a long-term supply agreement for the facilities to continue to manufacture existing Elanco products.   “Com...